John Varian
CIK: 0001416176
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLS
SELLAS Life Sciences Group, Inc.
Director
Discretionary Trading P&L
Holdings
About Varian John
Varian John (SEC CIK 0001416176) files insider reports with the SEC as Director of SELLAS Life Sciences Group, Inc. (SLS).
Signal8 holds 2 ownership filings by Varian John, all Form 4s, filed between Jan 14, 2025 and Jan 9, 2026. Those filings report 2 transactions, from Jan 10, 2025 to Jan 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Varian John's filings is in NEW YORK, NY.
Recent filings by Varian John
Other insiders filing for SELLAS Life Sciences Group, Inc. (SLS)
- Stergiou Angelos M., President and CEO
- VAN NOSTRAND ROBERT L, Director
- SCHEINBERG DAVID A, Director
- CICIC DRAGAN, SVP, Chief Development Officer
- Burns John Thomas, CFO
- Kalin Katherine Bach, Director